摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-(5-bromothiazol-2-yl)phenyl)ethanone | 810662-43-2

中文名称
——
中文别名
——
英文名称
1-(4-(5-bromothiazol-2-yl)phenyl)ethanone
英文别名
Ethanone, 1-[4-(5-bromo-2-thiazolyl)phenyl]-;1-[4-(5-bromo-1,3-thiazol-2-yl)phenyl]ethanone
1-(4-(5-bromothiazol-2-yl)phenyl)ethanone化学式
CAS
810662-43-2
化学式
C11H8BrNOS
mdl
——
分子量
282.161
InChiKey
VLKASLAMPHOPRG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    58.2
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • NOVEL S1P RECEPTOR MODULATING AGENT
    申请人:MEIJI SEIKA PHARMA CO., LTD.
    公开号:US20130217663A1
    公开(公告)日:2013-08-22
    An object of the present invention is to provide a compound having a modulating activity at an S1P receptor which is useful for preventing and treating autoimmune diseases, allergic diseases, and the like. According to the present invention, a compound represented by formula (I) or a pharmaceutically acceptable salt thereof is provided.
    本发明的一个目的是提供一种具有S1P受体调节活性的化合物,该化合物对于预防和治疗自身免疫疾病、过敏性疾病等是有用的。根据本发明,提供了一种由式(I)表示的化合物或其药学上可接受的盐。
  • Compounds and uses thereof in modulating amyloid beta
    申请人:Cheng Soan
    公开号:US20050070538A1
    公开(公告)日:2005-03-31
    Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.
    本发明提供了新的化合物,组合物和试剂盒。还提供了调节Aβ平的方法,以及治疗与异常Aβ平相关的疾病的方法。
  • COMPOUNDS AND USES THEREOF IN MODULATING AMYLOID BETA
    申请人:Cheng Soan
    公开号:US20070249833A1
    公开(公告)日:2007-10-25
    Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.
    提供了新型化合物、组合物和试剂盒。还提供了调节Aβ平的方法和治疗与异常Aβ平相关的疾病的方法。
  • Compounds and Uses Thereof in Modulating Amyloid Beta
    申请人:Cheng Soan
    公开号:US20070260058A1
    公开(公告)日:2007-11-08
    Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.
    本发明提供了新的化合物、组合物和试剂盒。还提供了调节Aβ平的方法以及治疗与异常Aβ平相关的疾病的方法。
  • ALPHA-HALOKETONE DERIVATIVES OF IMIDAZOLYL-SUBSTITUTED AROMATIC COMPOUNDS AND COMPOUNDS PREPARED THEREFROM
    申请人:Cheng Soan
    公开号:US20100331551A1
    公开(公告)日:2010-12-30
    Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.
    本发明提供了新的化合物、组合物和试剂盒。还提供了调节Aβ平的方法,以及治疗与异常Aβ平相关的疾病的方法。
查看更多